Antimineralocorticoids offer no benefit in heart attack patients without heart failure

Heart attack patients without heart failure derive no benefit from the addition of mineralocortoid receptor antagonists, to standard therapy, results of the ALBATROSS study show. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail